The German Cannabis Report
German Market Dataset (inc. Market Sizing)
£1495
This German cannabis market data package covers adult-use, medical and CBD markets. Specifically, it includes:
German Market Sizing Estimates up to 2028
- Medical market sizing and forecasting (inc. medical cannabis patient population forecasts)
- Pillar 2 Adult-use market sizing projections
- CBD market sizing and forecasting
Historic Medical Cannabis Import Data
- Volumes in Kilograms by country of import
Medical Cannabis Product Price Analysis
Insights into:
- Pricing
- Availability
- Country of origin
- Additional details about producers
- Specific product characteristics through informative charts
- Insights are categorised by format, specifically flowers and extracts
Cannabis Association Sales Projections
- Estimating for the short-term impact of cannabis associations on the adult-use market and comparing it to its future potential.
The German Cannabis Report
This German cannabis market data package covers adult-use, medical and CBD markets. Specifically, it includes: Market sizing estimates up to 2028 (Medical, Adult-Use & CBD); Sales projections for Cannabis Cultivation Associations; Medical cannabis import data; Reimbursed sales of medical cannabis (2018-2024); German cannabis investment analysis; Medical cannabis product(s) and pricing analysis. See the ‘Data Packages’ tab below for more information.
Contents
- Executive Summary
- Historical Context
- Adult-Use Cannabis
- Cannabis Associations
- Regulations
- Commercial Opportunities
- Personal Consumption
- Regulations
- Commercial Opportunities
- Home Cultivation
- Regulations
- Commercial Opportunities
- Pillar Two & Future Outlook
- Cannabis Associations
- Medical Cannabis
- Regulations
- Commercial Opportunities
- Products & Pricing
- CBD
- Regulations
- Current Landscape & Future Outlook
- Market Sizing
Second Wave of German Cannabis:
- Germany is experiencing a "second wave" of cannabis legalisation, marked by the Cannabis Act (CanG) which came into effect on 1 April 2024. This act legalised personal possession and consumption of cannabis, permitting individuals to possess up to 25 grams in public and 50 grams at home, and to cultivate up to three plants at home.
- This "second wave" builds on the "Cannabis as Medicine" law of 2017, which legalised medical cannabis but faced challenges in meeting initial expectations.
- The CanG Act's implementation has been met with relief and optimism, offering opportunities for investment and a more realistic outlook compared to the earlier hype of 2017.
Impact on the Medical Cannabis Market:
- The CanG Act has significantly impacted the medical cannabis market, simplifying access for patients and removing barriers for doctors, pharmacies, and distributors.
- Medical cannabis is no longer classified as a narcotic, enabling easier prescription and handling.
- Patient numbers are rising rapidly, with increased demand for medical cannabis through both traditional and telehealth channels.
- Domestic production and research into medical cannabis are now more feasible, paving the way for innovation from German companies.
- Costs for patients have decreased, with new reimbursement regulations under development to potentially further reduce expenses.
- Telemedicine clinics have emerged as a significant force in the medical cannabis market, offering patients convenient access to prescriptions and treatment.
Cannabis Cultivation Associations:
- The CanG Act introduced a framework for non-profit cannabis cultivation associations (also known as cannabis social clubs), permitting the communal cultivation and distribution of cannabis among members.
- Stringent regulations govern these associations, covering aspects like membership, cultivation, distribution, security, and record-keeping.
- These regulations, while aimed at public health and safety, are considered by some as overly restrictive, potentially hindering the establishment and operation of associations.
- Direct commercial opportunities within the association structure are limited to avoid profit-making.
- Indirect commercial opportunities exist for businesses providing services to associations, such as software solutions, property leasing, and consultancy.
- By September 2024, over 300 applications for cultivation associations had been submitted, with approvals varying across federal states.
- Lower Saxony demonstrated efficient processing, granting the first cultivation permit in the country.
- The report estimates that sales from cannabis associations could reach a monthly revenue of approximately €15 million (€180 million annually) if all registered associations obtain licences.
Personal Consumption and Home Cultivation:
- The CanG Act allows adults to cultivate up to three cannabis plants at home and possess up to 50 grams of dried cannabis at home.
- This has created commercial opportunities for businesses supplying cultivation and processing equipment, including grow tents, lights, nutrients, and rosin presses.
- Regulations surrounding personal consumption restrict public use, particularly near schools, playgrounds, and youth facilities.
- Driving limits for THC have been updated, with a new legal limit of 3.5ng/ml of THC in blood serum, accompanied by fines and penalties for exceeding this limit.
- Medical cannabis patients are exempt from these driving limits as long as they are not significantly impaired.
Pillar Two and Future Outlook:
- The CanG Act outlines a two-pillar model for cannabis reform. Pillar One focused on decriminalisation and cultivation associations, while Pillar Two aims to implement regional pilot projects with commercial and regulated cannabis supply chains.
- Pillar Two regulations are still under development, with no clear timeline for implementation.
- Some experts suggest that Pillar Two could potentially commence under the existing CanG Act provisions for scientific purposes.
- The 2025 federal elections could significantly impact the progress of Pillar Two, as a conservative victory could lead to its withdrawal.
- Several German cities have expressed interest in becoming model regions for Pillar Two pilot projects.
CBD Market:
- Germany has a large CBD market, dominated by CBD oils.
- Current regulations are complex and inconsistently enforced, creating uncertainty for CBD operators, particularly regarding the sale of CBD flower products.
- The "intoxication clause" in the Narcotics Act has led to legal challenges for CBD businesses handling flower products.
- Proposed regulations aim to remove the intoxication clause, allowing for the legal sale of CBD flowers and streamlining the market.
German Market Dataset (inc. Market Sizing)
£1495
This German cannabis market data package covers adult-use, medical and CBD markets. Specifically, it includes:
Market Sizing Forecasts - 2024-2028
- Medical Cannabis
- Adult-Use Cannabis
- CBD
- Patient Population
Cannabis Cultivation Associations
- Annual Revenue Forecasts (Based on Cultivation Applications)
- Annual Revenue Forecasts (Maximum Capacity)
- Number of Registered Associations (by Federal State)
- Number of Applications for Cultivation (by Federal State)
Medical Cannabis Import Data - 2017-2024
- Volume (Kg) by Country of Import
- 25 Different Countries Featured
Reimbursed Sales of Medical Cannabis - 2018-2024
- Cannabis Flowers in Preparation (Granulated, Portioned etc.)
- Cannabis Flowers (Unchanged)
- Cannabinoid-based Pharmaceuticals Without a Pharmacentral Number
- Finished Extracts
German Cannabis Investment Analysis
- Over 30 Companies
- Investment Size
- Investment Type
- Investor
- Investor Country
Medical Cannabis Products
- Availability Status
- Price Analysis
- Country of Origin
- Producers & Brands
- Most Frequent Strains
As Trusted By
Insights
on the global cannabis industry
International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.